What Is Methylergonovine Used to Treat?
Methylergonovine maleate salt is primarily utilized to prevent and manage postpartum hemorrhage, which refers to excessive bleeding following childbirth. As a semisynthetic ergot alkaloid, it functions as a uterotonic agent, stimulating the contraction of uterine muscles. By inducing uterine contractions, methylergonovine helps control bleeding by compressing the blood vessels that supply the uterus.
Normally controlled intramuscularly or intravenously following the conveyance of the placenta, methylergonovine can likewise be given prophylactically during the third phase of work to forestall post pregnancy drain, especially in ladies in danger because of variables like a past filled with post pregnancy draining or uterine atony (absence of uterine muscle tone).
Beyond its primary obstetric application, methylergonovine may also be used off-label for other medical conditions, including:
Migraine headaches: Methylergonovine's ability to constrict cranial blood vessels can help alleviate migraine pain. It is often considered in cases where other migraine treatments have been ineffective.
Uterine bleeding: In cases of abnormal uterine bleeding not related to childbirth, such as menorrhagia (heavy menstrual bleeding), methylergonovine may be prescribed to help control bleeding by promoting uterine contractions.
Gastrointestinal bleeding: Methylergonovine's vasoconstrictive properties make it potentially useful in reducing bleeding from the stomach or intestines. It can help constrict blood vessels, thereby decreasing blood loss from gastrointestinal sources.
While methylergonovine is compelling for these circumstances, its utilization ought to be painstakingly thought of, particularly in people with specific ailments or who are taking different drugs, because of the gamble of unfriendly impacts. It's essential for healthcare providers to evaluate each patient's medical history and overall health status before prescribing Methylergonovine maleate salt for any indication.
How Does Methylergonovine Maleate Work?
Methylergonovine maleate salt, a derivative of the ergot alkaloid ergonovine, is primarily used in obstetrics for its uterotonic properties, aiding in the prevention or treatment of postpartum hemorrhage and the management of uterine atony following childbirth or abortion. Its mechanism of action involves several interactions within the body, particularly with serotonin and dopamine receptors.
Stimulation of Serotonin Receptors: Methylergonovine goes about as an agonist at serotonin receptors, especially the 5-HT2A and 5-HT2B subtypes, tracked down in uterine smooth muscle cells. Actuation of these receptors prompts an expansion in intracellular calcium levels inside the smooth muscle cells.
Increased Calcium Levels: The ascent in intracellular calcium focus sets off a fountain of occasions, eventually bringing about the withdrawal of uterine smooth muscle strands. This contraction is essential for controlling postpartum bleeding and promoting involution of the uterus after childbirth.
Direct Action on Smooth Muscle Cells: In addition to its serotonergic effects, methylergonovine also directly influences uterine smooth muscle cells. This direct action further enhances uterine contractions, contributing to its effectiveness as a uterotonic agent.
Vasoconstrictor Properties: Methylergonovine also exhibits vasoconstrictor effects, primarily through its interaction with dopamine receptors, particularly the D2 subtype, present in blood vessels. By stimulating these receptors, methylergonovine causes constriction of blood vessels, which can be beneficial in certain clinical scenarios.
In clinical practice, methylergonovine is administered either orally or by injection, depending on the specific indication and patient circumstances. It means a lot to take note of that while methylergonovine is successful for its planned purposes, it ought to be utilized circumspectly and under clinical watch because of its capability to prompt vasoconstriction, which can prompt unfriendly impacts like hypertension and ischemia, especially in patients with cardiovascular illness or hypertension.
Overall, Methylergonovine maleate salt 's multifaceted mechanism of action, involving serotonin and dopamine receptors, makes it a valuable therapeutic agent in obstetrics for managing postpartum hemorrhage and uterine atony. Additionally, its vasoconstrictor properties extend its utility to other medical conditions such as migraine headaches and gastrointestinal bleeding, although its use in these contexts requires careful consideration of potential side effects and contraindications.
What Are the Side Effects and Precautions of Methylergonovine?
While Methylergonovine maleate salt is an effective medication for preventing and treating postpartum hemorrhage, it is associated with several potential side effects and precautions that should be considered.
Secondary effects:
The most widely recognized symptoms of methylergonovine include:
- Sickness and regurgitating
- Cerebral pain
- Wooziness
- Hypertension (hypertension)
- Chest torment or snugness
- Leg cramps
- Flushing or sensation of warmth
More uncommon however more serious secondary effects might include:
- Coronary course vasospasm, prompting myocardial localized necrosis (respiratory failure)
- Cerebral vasospasm, possibly causing stroke or seizures
- Gangrene or serious fringe ischemia (insufficient blood supply to the furthest points)
- Hypertensive emergency (seriously raised circulatory strain)
- Aspiratory edema (liquid development in the lungs)
Precautionary measures:
Because of the potential for serious antagonistic impacts, methylergonovine ought to be involved with alert in the accompanying circumstances:
- Cardiovascular sickness: Methylergonovine is contraindicated in patients with hypertension, coronary corridor illness, or other critical cardiovascular circumstances.
- Fringe vascular illness: The medication ought to be kept away from in patients with conditions that increment the gamble of fringe ischemia, like Raynaud's sickness or thromboangiitis obliterans.
- Hepatic or renal impairment: Dose adjustments may be necessary in patients with liver or kidney dysfunction.
- Hyperthyroidism: Methylergonovine may exacerbate the symptoms of hyperthyroidism.
- Breastfeeding: The drug may suppress lactation and should be used with caution in breastfeeding mothers.
Healthcare providers should carefully weigh the potential benefits of methylergonovine against the risks, particularly in patients with underlying medical conditions or risk factors for adverse effects.
References:
1. Methylergonovine Maleate. In: Lexi-Drugs Online [Internet]. Hudson (OH): Lexicomp Inc.; [updated 2023 Mar 13; cited 2023 Mar 21]. Available from: https://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/6642
2. Methylergonovine Maleate. In: IBM Micromedex [Internet]. Greenwood Village (CO): IBM Corporation; [updated 2023 Mar 10; cited 2023 Mar 21]. Available from: https://www.micromedexsolutions.com
3. Bouwmeester FW, Bolte AC, van Geijn HP. Pharmacological and cardiovascular effects of methylergometrine and methylergonovine in women with hypertensive disease in pregnancy. Eur J Obstet Gynecol Reprod Biol. 1988;29(1):51-62.
4. Derry S, Sven-Åke R, Moore RA. Methylergonovine maleate in the prevention and treatment of post-partum haemorrhage: a review. J Obstet Gynaecol. 2005;25(8):751-757.
5. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2015.
6. Methylergonovine Maleate. In: DrugBank Online [Internet]. Edmonton (AB): University of Alberta; [updated 2023 Feb 13; cited 2023 Mar 21]. Available from: https://go.drugbank.com/drugs/DB00847